Studies have shown that there is a significant increase in HSPG production in glioma and the dense ECM leads to hypoxia and tumor aggressiveness (Wade et al., 2013; Lemjabbar-Alaoui et al., 2015). The gene discussed is HSPG2; the disease is central nervous system cancer.